CRYO-CELL INTERNATIONAL, INC. Ratio of Indebtedness to Net Capital
CRYO-CELL INTERNATIONAL, INC. (CCEL) had Ratio of Indebtedness to Net Capital of 350.00% as of 2026-05-31, per its 10-Q filed 2026-07-15.
Financial Statements › Notes › Debt
us-gaap:RatioOfIndebtednessToNetCapital1 · last filed 2026-07-15
- 2026-05-31: Ratio of Indebtedness to Net Capital 350.00%.
- 2026-02-28: Ratio of Indebtedness to Net Capital 350.00%.
- 2025-11-30: Ratio of Indebtedness to Net Capital 350.00%.
- 2025-08-31: Ratio of Indebtedness to Net Capital 350.00%.
| Period end | Ratio of Indebtedness to Net Capital |
|---|---|
| 2026-05-31 | 350.00% 10-Q · filed 2026-07-15 |
| 2026-02-28 | 350.00% 10-Q · filed 2026-04-14 |
| 2025-11-30 | 350.00% 10-K · filed 2026-02-27 |
| 2025-08-31 | 350.00% 10-Q · filed 2025-10-15 |
| 2025-05-31 | 350.00% 10-Q · filed 2025-07-15 |
| 2025-02-28 | 350.00% 10-Q · filed 2025-04-14 |
| 2024-11-30 | 350.00% 10-K · filed 2025-02-28 |
| 2024-08-31 | 350.00% 10-Q · filed 2024-10-15 |
| 2024-05-31 | 350.00% 10-Q · filed 2024-07-15 |
| 2024-02-29 | 350.00% 10-Q · filed 2024-04-15 |
| 2023-11-30 | 350.00% 10-K · filed 2024-02-28 |
| 2023-08-31 | 350.00% 10-Q · filed 2023-10-12 |
| 2023-05-31 | 350.00% 10-Q · filed 2023-07-14 |
| 2023-02-28 | 350.00% 10-Q · filed 2023-04-21 |
| 2022-11-30 | 350.00% 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |